BORREGAARD BIOPLANT ApS: Financial statements 2022
CVR: 21500445
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BORREGAARD BIOPLANT ApS (CVR 21500445) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 10,002,306 and a net result of DKK -1,458,607 compared with DKK 900,159 the year before. That is a decrease of 14.9% compared with the year before. Equity in the 2022 report amounted to DKK 7,361,987. The solvency ratio was 67.3%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 10,002,306
- Profit/Loss
- DKK -1,458,607
- Equity
- DKK 7,361,987
- Total Assets
- DKK 10,932,436
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 10M | -1.5M | 7.4M | 21 |
| 2021 | - | 11.8M | 900K | 9.8M | 20 |
| 2020 | - | 11.5M | 596K | 8.9M | 19 |
| 2019 | - | 9.1M | 211K | 8.3M | 20 |
| 2018 | - | 9.3M | 1.2M | 8.2M | 16 |
Official annual report
Keep an eye on BORREGAARD BIOPLANT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 31, 2022, Steen Borregaard has stepped down as director of BORREGAARD BIOPLANT ApS.
As of October 1, 2022, Martin Lemche has joined the board of directors of BORREGAARD BIOPLANT ApS.
As of September 30, 2022, Torben Huus-Bruun has left the board of directors of BORREGAARD BIOPLANT ApS.
BORREGAARD BIOPLANT ApS has published its annual report for 2021. Gross profit came to DKK 11,756,817, and the net result was DKK 900,159.
As of January 21, 2022, A/S PSE 17 NR. 1056 has stepped down as auditor of BORREGAARD BIOPLANT ApS.
About BORREGAARD BIOPLANT ApS
BORREGAARD BIOPLANT ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 1999. The company is registered under the industry Ikke-specialiseret engroshandel. The company was previously named REITZEL BIOPLANT ApS and PBH 26.815 ApS. The management consists of Martin Lemche. The board consists of Jean-Marc Maurice Denis Vandoorne-Feys (chair), Erik Desire V. Vanderhaegen, Marc Domien Josephina Mertens and Martin Lemche. The company is owned by Biobest Group NV. The company has 29 employees (2026). In 2025, the company reported a gross profit of DKK 10,536,766 and a net result of DKK 491,045 compared with DKK 421,195 the year before. Equity in the 2025 report amounted to DKK 5,520,385.